Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
A Dark Horse Five Years In The Making: Legend Gains First Global Approval
First 'Made in China' Cell Therapy In US
Mar 02 2022
•
By
Brian Yang
LEGEND'S CARVYKTI RACES TO BECOME SECOND BAMA CAR-T THERAPY IN THE US • Source: Shutterstock/ParabolStudio
More from China
More from Focus On Asia